Cite
HARVARD Citation
Kopylov, U. et al. (2018). Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European Study. Inflammatory bowel diseases. 24 (11), pp. 2442-2451. [Online].